Navigation Links
Study Evaluates Laser Therapies for Hair Removal
Date:10/20/2008

Findings suggest combo treatments less effective, more painful than singular procedures

MONDAY, Oct. 20 (HealthDay News) -- Laser therapies to remove unwanted hair may be safer and more effective when used separately rather than in combination, according to an Iranian study.

The researchers at the Baqiyatallah University of Medical Sciences in Tehran compared the removal of hair on the legs of 15 people using either long-pulsed 755-nanometer alexandrite lasers (12- and 18-millimeter spot sizes), long-pulsed 1,064 nanometer Nd:YAG laser (12-millimeter spot size), or a combination of alexandrite and Nd:YAG 12-millimeter spot size lasers.

The participants received a total of four treatment sessions at eight-week intervals. Average hair density was measured with a hair counting device and special software, and hair reduction was assessed by comparing digital photographs taken before treatment and at eight- and 18-month follow-up sessions.

Average hair reductions 18 months after final treatment were 75.9 percent for the 12-millimeter spot size alexandrite laser, 84.3 percent for the 18-millimeter spot size alexandrite laser, 73.6 percent for the Nd:YAG laser, and 77.8 percent for the combination therapy.

Leg areas that received the alexandrite laser treatments had higher average pain severity than those treated with the Nd:YAG laser. The highest amount of pain occurred in areas that received the combination treatment. Those areas were also most likely to have hyperpigmentation (dark spots on the skin).

"Despite other studies showing more efficacy of the alexandrite rather than the Nd:YAG laser, our trial results showed no significant difference between them," the study authors concluded. "The use of alexandrite or Nd:YAG laser systems alone for at least four treatments sessions and with eight-week intervals have long-term persistent efficacy in hair reduction with acceptable and transient adverse ef
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. New Study Reveals Consumers Want Greater Say in Key Food Issues
2. American Association for the Study of Liver Diseases Enters Into Agreement With Clinical Care Options as Its Authorized Online Conference Coverage Provider for the Liver Meeting(R) 2008
3. InHealth awards grants to study impact of medical diagnostics and devices on patients, health care
4. American Association for the Study of Liver Diseases (AASLD) Presidents Press Conference, Nov. 1, 2008 in San Francisco
5. Death rate 70 percent lower at top-rated hospitals: HealthGrades annual hospital quality study
6. Study examines association between caffeine consumption and breast cancer risk
7. Advanced Circulatory Systems Receives $1.5 Million From NIH for Study of Cardiac Arrest Resuscitation Techniques
8. 3 Michigan Counties Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
9. National Psoriasis Foundation Releases 2008 Study Results
10. Steroid treatment offers no benefit in preemies, Hopkins Childrens study suggests
11. Florida study finds barriers to angioplasty for life-threatening heart attacks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Evaluates Laser Therapies for Hair Removal
(Date:5/23/2013)... 2013 Vegas Hotel Escapes, the ... announce all new vacation packages for the upcoming ... Las Vegas for this patriotic holiday will be ... to VegasHotelEscapes.com's new special pricing available on VegasHotelEscapes.com's ... it guarantees the lowest prices possible on vacation ...
(Date:5/23/2013)... New Jersey (PRWEB) May 23, 2013 ... Americans suffering from irritable bowel syndrome (IBS), the food ... on your holiday fun. , “While hot dogs and ... plate during the warm weather months, IBS sufferers often ... says Deborah Sokol, MD, a gastroenterologist with Lourdes Medical ...
(Date:5/23/2013)... 23, 2013 Onlinefitnessreview.com recently published a ... to determine what makes this diet work and how ... highlights three main components of the program: eliminating foods ... mindset and the personal motivation that is needed to ... days to keep the metabolism rate in top gear. ...
(Date:5/23/2013)... Mann HealthDay Reporter , , THURSDAY, May 23 ... take to help treat hip and knee osteoarthritis may ... for developing glaucoma, a small new study of older ... an increase of intraocular pressure (IOP) or pressure inside ... leading causes of blindness. In the ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Memorial Day ... , Chaplains have been a part of the U.S. ... Day, like those preceding it, these men and women ... the United States of America. As veterans transition ... their migration to the workplace chaplaincy world. , ...
Breaking Medicine News(10 mins):Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 2Health News:Sensitive Stomach? Lourdes Gastroenterologist Advises IBS Sufferers to Think Twice About What They Eat This Holiday Weekend 3Health News:Onlinefitnessreview.com Publishes 7 Day Belly Blast Diet Review 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 2Health News:Glucosamine Supplements Tied to Risk of Eye Condition 3Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 2Health News:Memorial Day Focus Spotlight on Military Chaplains Transitioning in the Marketplace 3
... affect psychological well-being, , FRIDAY, Sept. 25 (HealthDay News) -- ... lose IQ points. , The good news is that it ... at least one expert believes that part of the reason ... in the United States and elsewhere. , That,s the view ...
... Life ... with one of its Northwest Division President,s Awards on Monday, Sept. 21. , ... Kirkland, WA (PRWEB) September 25, 2009 -- ... Care Center of Kirkland , with one of its Northwest Division President,s Awards on Monday, ...
... ... portable oxygen machine from Invacare with an amazing 1.8 liters per minute ... oxygen output. Now, oxygen therapy patients requiring large doses of oxygen can ... mobility and freedom. This new portable concentrator is now available for online ...
... researchers say , THURSDAY, Sept. 24 (HealthDay News) -- ... with carpal tunnel syndrome who don,t have severe nerve ... included 44 patients who had surgery and 52 patients ... ultrasound. A year after treatment, the patients, hand function ...
... CA SEPTEMER 24, 2009 Results from a ... combination of giving patients clopidogrel, a blood thinner commonly ... such as omeprazole, known as proton pump inhibitors (PPIs), ... studies had suggested. The results were presented at the ...
... BEDFORD, Mass., Sept. 24 ... HOLX ), a leading developer, manufacturer and supplier ... dedicated to serving the healthcare needs of women, today ... Clinical Excellence (NICE), in its updated guidance for hysteroscopic ...
Cached Medicine News:Health News:Spanking May Lower Kids' IQs 2Health News:Spanking May Lower Kids' IQs 3Health News:Local Nursing Home Leader Receives Life Care's Northwest Division President's Award 2Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 2Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 3Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 4Health News:New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 5Health News:Surgery Best for Carpal Tunnel Syndrome 2Health News:Surgery Best for Carpal Tunnel Syndrome 3Health News:Cogent trial shows lack of adverse interaction between clopidogrel and stomach medicine 2Health News:New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System 2Health News:New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System 3Health News:New U.K. NICE Guidance Supports Use of Hologic's Adiana(R) Permanent Contraception System 4
(Date:5/23/2013)... 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... 2013 Life Science Firm of the Year by the Tech ... honored at the TCM,s 25 th Annual Tech Awards ... Tech Awards Celebration recognizes the leaders and innovators in the ... and the surrounding regions. "We are ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 /PRNewswire/ ... destacado desarrollador y fabricante de herramientas de precisión ... y tratamiento de la enfermedad vascular periférica y ... ADVISE ( Ad enosine V asodilator ... II durante la sesión de ensayo clínico hot ...
(Date:5/23/2013)... , May 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... Gorman , President and Chief Executive Officer of Neurocrine ... Annual dbAccess Health Care Conference in Boston.   ... at 11:20 a.m. Eastern Time / 8:20 a.m. Pacific Time.  ... the Company,s website at http://www.neurocrine.com . ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6
... 2 "A two-year,survival rate of more ... anaplastic,astrocytoma suggests a breakthrough in this devastating ... Neuro-Oncologist and Coordinating,Investigator of the Phase IIb ... or refractory high-grade glioma, while presenting the,data ...
... American Transplant Congress in Toronto, MIAMI, June ... in,the Departments of Surgery and Pathology at the ... have corroborated the value of,monitoring cell- mediated immunity ... a regular laboratory assay of cell function,(ImmuKnow(R)/Cylex). Their ...
Cached Medicine Technology:Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 2Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 3Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 4University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 2University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 3University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: